| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259947A 2-aryl-naphthyridin-4-ones as antitumor agent |
| 07/12/2000 | CN1259946A Ergoline derivatives and their use as somatostatin receptor antagonists |
| 07/12/2000 | CN1259944A Treatments of prophylaxis of prostatic cancer and benign prostatic hyperplasia |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 07/12/2000 | CN1259868A Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for treating cancer |
| 07/12/2000 | CN1259866A Therapeutic treatment for skin disorders |
| 07/12/2000 | CN1259366A Traditional Chinese medicinal pill benefiting kidney and primordial energy |
| 07/12/2000 | CN1259361A Chinee medicinal power for treating toothache and its prepn. method |
| 07/12/2000 | CN1259356A Wine made of delicacies from mountain capable of preserving one's health and prepn. method thereof |
| 07/12/2000 | CN1259352A Whole deer prepn. |
| 07/12/2000 | CN1259339A Washing agent prepns. compositions |
| 07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
| 07/12/2000 | CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/12/2000 | CN1054292C Chinese proprietary medicine for treating hemiplegia |
| 07/11/2000 | US6087509 Derivatives of trifluorobenzonitriles |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087377 Reducing the side effects associated with anticancer drug irinotecan by administering an antiestrogen at least two cell cycles prior to administration of the irinotecan |
| 07/11/2000 | US6087370 Methods of treatment using lamellarin-class alkaloids |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof |
| 07/11/2000 | US6087362 Treating erectile dysfunction in a human patients by administering prior to sexual activity |
| 07/11/2000 | US6087360 Method of treating heart failure with endothelin antagonists |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/11/2000 | US6087350 Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
| 07/11/2000 | US6087339 Saccharide derivatives |
| 07/11/2000 | US6087338 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087168 Obtaining basal epidermal cells, transfecting with expression vectors coding for neurogenic transcription factors, adding antisense oligonucleotide to suppress negative regulators of neuronal differentiation, culturing with retinoid and factors |
| 07/11/2000 | US6087167 Promoting neuron survival or neurite outgrowth by contacting neurons with an amount of an eck receptor binding protein of specific amino acid sequence |
| 07/11/2000 | US6087160 Programmed cell death genes and proteins |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 07/11/2000 | US6087144 Mammalian enzymatic protein receptor; for the activation of cell differentiation and propagation; for screening modulators or receptor activity |
| 07/11/2000 | US6086919 Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 07/11/2000 | US6086898 Administering listeria adjuvants and antigens for immunology |
| 07/11/2000 | US6086894 Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/11/2000 | US6086878 By administering a gastrointestinal neuromodulator antibody, such as antibodies to bombesin, cholecystokinin, gastrin, somatostatin, and neuropeptide y; for egg or milk-producing animals |
| 07/11/2000 | US6086874 Kit comprising an interleukin-6 (il-6) antagonist such as antibody to il-6, antibody to il-6 receptor, and antibody to gp130 protein, an antitumor agent such as cisplatin, and a carrier; antagonist and antitumor agent not physically bonded |
| 07/11/2000 | US6086867 By contacting the cell with a soluble polypeptide comprising the amino acid sequence of the extracellular domain of the transforming growth factor-beta (tgf-b) type iii receptor protein or mammalian dna encoding it |
| 07/11/2000 | US6086789 Medical uses of pyruvates |
| 07/11/2000 | CA2019231C Novel acetylcholinesterase inhibitors |
| 07/06/2000 | WO2000039716A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
| 07/06/2000 | WO2000039589A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | WO2000039347A1 A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039292A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039249A1 Ume extract having medicinal effects and compositions containing the same |
| 07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | WO2000039165A1 Serine protease inhibitor |
| 07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | WO2000039140A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same |
| 07/06/2000 | WO2000039128A1 5ht1 antagonists for antidepressant therapy |
| 07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039120A2 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039115A1 Protease inhibitors |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039111A1 Antithrombotic amides |
| 07/06/2000 | WO2000039097A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | WO2000039096A1 2-methylimidazoline compounds |
| 07/06/2000 | WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 07/06/2000 | WO2000039083A2 Pyrazole compounds and uses thereof |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038727A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038724A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038716A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 07/06/2000 | WO2000038697A1 Treatment and prevention of hiv and other viral infections |
| 07/06/2000 | WO2000038694A1 Medicinal compositions for treating osseous lesion in multiple myeloma |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038686A1 Controlled release galantamine composition |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038677A1 Indole and indolizidine derivatives for the treatment of migraine |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038661A2 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life |
| 07/06/2000 | WO2000038618A2 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 07/06/2000 | WO2000038536A2 Inhibitors of the bitter taste response |
| 07/06/2000 | WO2000022125A3 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |